Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beam Therapeutics (BEAM) Prepaid Assets: 2019-2024

Historic Prepaid Assets for Beam Therapeutics (BEAM) over the last 6 years, with Dec 2024 value amounting to $27.4 million.

  • Beam Therapeutics' Prepaid Assets rose 19.21% to $23.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $23.6 million, marking a year-over-year increase of 19.21%. This contributed to the annual value of $27.4 million for FY2024, which is 29.49% up from last year.
  • Beam Therapeutics' Prepaid Assets amounted to $27.4 million in FY2024, which was up 29.49% from $21.2 million recorded in FY2023.
  • Beam Therapeutics' Prepaid Assets' 5-year high stood at $27.4 million during FY2024, with a 5-year trough of $7.4 million in FY2021.
  • Moreover, its 3-year median value for Prepaid Assets was $21.2 million (2023), whereas its average is $21.1 million.
  • Per our database at Business Quant, Beam Therapeutics' Prepaid Assets spiked by 220.85% in 2020 and then fell by 14.91% in 2021.
  • Over the past 5 years, Beam Therapeutics' Prepaid Assets (Yearly) stood at $8.7 million in 2020, then declined by 14.91% to $7.4 million in 2021, then skyrocketed by 100.57% to $14.8 million in 2022, then soared by 43.39% to $21.2 million in 2023, then climbed by 29.49% to $27.4 million in 2024.